nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: Biochemical evidence and therapeutic perspectives
|
Borgo, Christian |
|
2013 |
|
6 |
p. 1103-1115 13 p. |
artikel |
2 |
Acquired and intrinsic resistance in cancer immunotherapy
|
Kelderman, Sander |
|
2014 |
|
6 |
p. 1132-1139 8 p. |
artikel |
3 |
Acquired resistance to EGFR-targeted therapies in colorectal cancer
|
Van Emburgh, Beth O. |
|
2014 |
|
6 |
p. 1084-1094 11 p. |
artikel |
4 |
Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals
|
Chen, Zhuo-Jia |
|
2016 |
|
6 |
p. 775-788 14 p. |
artikel |
5 |
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer
|
Irish, Jonathan C. |
|
2016 |
|
6 |
p. 850-865 16 p. |
artikel |
6 |
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
|
Kollmorgen, Gwendlyn |
|
2013 |
|
6 |
p. 1142-1151 10 p. |
artikel |
7 |
Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma
|
Damhofer, Helene |
|
2013 |
|
6 |
p. 1031-1042 12 p. |
artikel |
8 |
Brain metastasis: New opportunities to tackle therapeutic resistance
|
Seoane, Joan |
|
2014 |
|
6 |
p. 1120-1131 12 p. |
artikel |
9 |
Cancer drug resistance: Old concept, novel solutions required
|
Peeper, Daniel S. |
|
2014 |
|
6 |
p. 1064-1066 3 p. |
artikel |
10 |
Cancer, epigenetics and the Nobel Prizes
|
Esteller, Manel |
|
2012 |
|
6 |
p. 565-566 2 p. |
artikel |
11 |
Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology
|
Karagiannis, George S. |
|
2010 |
|
6 |
p. 496-510 15 p. |
artikel |
12 |
Challenges and Opportunities in Oncoproteomics
|
Celis, Julio E. |
|
2010 |
|
6 |
p. 459-460 2 p. |
artikel |
13 |
Chromatin remodeling in Cancer: A Gateway to regulate gene Transcription
|
Nair, Sujit S. |
|
2012 |
|
6 |
p. 611-619 9 p. |
artikel |
14 |
Contents of Molecular Oncology Volume 4
|
|
|
2010 |
|
6 |
p. 562-566 5 p. |
artikel |
15 |
c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion
|
Wang, Liyang |
|
2013 |
|
6 |
p. 1116-1128 13 p. |
artikel |
16 |
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease
|
Jansen, Maurice P.H.M. |
|
2015 |
|
6 |
p. 1218-1233 16 p. |
artikel |
17 |
Detection of cancer-specific epigenomic changes in biofluids: Powerful tools in biomarker discovery and application
|
Nogueira da Costa, André |
|
2012 |
|
6 |
p. 704-715 12 p. |
artikel |
18 |
Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial
|
Dekker, T.J.A. |
|
2015 |
|
6 |
p. 1120-1128 9 p. |
artikel |
19 |
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
|
Allensworth, Jennifer L. |
|
2015 |
|
6 |
p. 1155-1168 14 p. |
artikel |
20 |
DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer
|
Kurfurstova, Daniela |
|
2016 |
|
6 |
p. 879-894 16 p. |
artikel |
21 |
DNA methylation and microRNA dysregulation in cancer
|
Suzuki, Hiromu |
|
2012 |
|
6 |
p. 567-578 12 p. |
artikel |
22 |
Drug resistance to targeted therapies: Déjà vu all over again
|
Groenendijk, Floris H. |
|
2014 |
|
6 |
p. 1067-1083 17 p. |
artikel |
23 |
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody
|
Cignetto, Simona |
|
2016 |
|
6 |
p. 938-948 11 p. |
artikel |
24 |
Editorial Board
|
|
|
2010 |
|
6 |
p. ii- 1 p. |
artikel |
25 |
Editorial Board
|
|
|
2014 |
|
6 |
p. ii- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
2015 |
|
6 |
p. ii- 1 p. |
artikel |
27 |
Editorial Board
|
|
|
2016 |
|
6 |
p. ii- 1 p. |
artikel |
28 |
Editorial Board
|
|
|
2013 |
|
6 |
p. ii- 1 p. |
artikel |
29 |
Editorial Board
|
|
|
2011 |
|
6 |
p. ii- 1 p. |
artikel |
30 |
Editorial Board
|
|
|
2012 |
|
6 |
p. ii- 1 p. |
artikel |
31 |
Epigenetic alterations involved in cancer stem cell reprogramming
|
Muñoz, Purificación |
|
2012 |
|
6 |
p. 620-636 17 p. |
artikel |
32 |
Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocation
|
Kim, Hyeong Ryul |
|
2013 |
|
6 |
p. 1093-1102 10 p. |
artikel |
33 |
Erratum to “Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients” [MOLONC 8 (2014) 741–752]
|
Tobin, Nicholas P. |
|
2014 |
|
6 |
p. 1159- 1 p. |
artikel |
34 |
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
|
Jensen, Niels F. |
|
2015 |
|
6 |
p. 1169-1185 17 p. |
artikel |
35 |
Focal adhesion kinase inhibitors are potent anti-angiogenic agents
|
Cabrita, Miguel A. |
|
2011 |
|
6 |
p. 517-526 10 p. |
artikel |
36 |
Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast
|
Vidal, Maria |
|
2015 |
|
6 |
p. 1081-1090 10 p. |
artikel |
37 |
Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis
|
Carter, Daniel R. |
|
2016 |
|
6 |
p. 866-878 13 p. |
artikel |
38 |
HDAC inhibitor-based therapies: Can we interpret the code?
|
New, Maria |
|
2012 |
|
6 |
p. 637-656 20 p. |
artikel |
39 |
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
|
Grupp, Katharina |
|
2013 |
|
6 |
p. 1001-1011 11 p. |
artikel |
40 |
Histone deacetylases and cancer
|
Barneda-Zahonero, Bruna |
|
2012 |
|
6 |
p. 579-589 11 p. |
artikel |
41 |
Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
|
Brambilla, Lara |
|
2015 |
|
6 |
p. 1194-1206 13 p. |
artikel |
42 |
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women
|
Sieuwerts, Anieta M. |
|
2011 |
|
6 |
p. 504-516 13 p. |
artikel |
43 |
Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory
|
De Braekeleer, Etienne |
|
2011 |
|
6 |
p. 555-563 9 p. |
artikel |
44 |
IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma
|
Peng, Hsuan-Yu |
|
2016 |
|
6 |
p. 895-909 15 p. |
artikel |
45 |
Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer
|
Liu, Chen |
|
2011 |
|
6 |
p. 545-554 10 p. |
artikel |
46 |
Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
|
Borgan, Eldrid |
|
2011 |
|
6 |
p. 564-576 13 p. |
artikel |
47 |
Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo
|
Conrotto, Paolo |
|
2011 |
|
6 |
p. 527-537 11 p. |
artikel |
48 |
Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels
|
Haldrup, Christa |
|
2016 |
|
6 |
p. 825-837 13 p. |
artikel |
49 |
Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells
|
Forn, Marta |
|
2013 |
|
6 |
p. 1129-1141 13 p. |
artikel |
50 |
MALDI Imaging Mass Spectrometry – Painting Molecular Pictures
|
Schwamborn, Kristina |
|
2010 |
|
6 |
p. 529-538 10 p. |
artikel |
51 |
Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs
|
Cheng, Xinlai |
|
2016 |
|
6 |
p. 806-824 19 p. |
artikel |
52 |
MicroRNA and cancer
|
Jansson, Martin D. |
|
2012 |
|
6 |
p. 590-610 21 p. |
artikel |
53 |
MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer
|
Shukla, Kirti |
|
2015 |
|
6 |
p. 1106-1119 14 p. |
artikel |
54 |
MicroRNA-548j functions as a metastasis promoter in human breast cancer by targeting Tensin1
|
Zhan, Yun |
|
2016 |
|
6 |
p. 838-849 12 p. |
artikel |
55 |
MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase
|
Mäki-Jouppila, Jenni Heidi Eveliina |
|
2015 |
|
6 |
p. 1056-1070 15 p. |
artikel |
56 |
Molecular-targeted nanotherapies in cancer: Enabling treatment specificity
|
Blanco, Elvin |
|
2011 |
|
6 |
p. 492-503 12 p. |
artikel |
57 |
Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation
|
Kievit, Forrest M. |
|
2015 |
|
6 |
p. 1071-1080 10 p. |
artikel |
58 |
Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation
|
Brüning, Ansgar |
|
2013 |
|
6 |
p. 1012-1018 7 p. |
artikel |
59 |
New members of the editorial board – Personal profiles
|
Pedersen, Dorte Holst |
|
2014 |
|
6 |
p. 1055-1056 2 p. |
artikel |
60 |
NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer
|
Kaunisto, Aura |
|
2015 |
|
6 |
p. 1140-1154 15 p. |
artikel |
61 |
NFIB is a potential target for estrogen receptor-negative breast cancers
|
Moon, Hyeong-Gon |
|
2011 |
|
6 |
p. 538-544 7 p. |
artikel |
62 |
No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients
|
Girotti, Maria Romina |
|
2014 |
|
6 |
p. 1140-1158 19 p. |
artikel |
63 |
Non-coding RNAs in cancer initiation and progression and as novel biomarkers
|
Nana-Sinkam, S. Patrick |
|
2011 |
|
6 |
p. 483-491 9 p. |
artikel |
64 |
Novel sesquiterpene lactone analogues as potent anti-breast cancer agents
|
Nakagawa-Goto, Kyoko |
|
2016 |
|
6 |
p. 921-937 17 p. |
artikel |
65 |
Phosphoproteomics in cancer
|
Harsha, H.C. |
|
2010 |
|
6 |
p. 482-495 14 p. |
artikel |
66 |
PICan: An integromics framework for dynamic cancer biomarker discovery
|
McArt, Darragh G. |
|
2015 |
|
6 |
p. 1234-1240 7 p. |
artikel |
67 |
p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia
|
Zhang, Jun |
|
2013 |
|
6 |
p. 1069-1082 14 p. |
artikel |
68 |
Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours – A prognostic test after surgical resection
|
Kolberg, Matthias |
|
2015 |
|
6 |
p. 1129-1139 11 p. |
artikel |
69 |
Reading between the lines; understanding drug response in the post genomic era
|
Alifrangis, Constantine C. |
|
2014 |
|
6 |
p. 1112-1119 8 p. |
artikel |
70 |
Reverse phase protein microarrays advance to use in clinical trials
|
Mueller, Claudius |
|
2010 |
|
6 |
p. 461-481 21 p. |
artikel |
71 |
RhoC and ROCKs regulate cancer cell interactions with endothelial cells
|
Reymond, Nicolas |
|
2015 |
|
6 |
p. 1043-1055 13 p. |
artikel |
72 |
Selective inhibition of tumor cell associated Vacuolar-ATPase ‘a2’ isoform overcomes cisplatin resistance in ovarian cancer cells
|
Kulshrestha, Arpita |
|
2016 |
|
6 |
p. 789-805 17 p. |
artikel |
73 |
SPARCL1 suppresses metastasis in prostate cancer
|
Xiang, Yuzhu |
|
2013 |
|
6 |
p. 1019-1030 12 p. |
artikel |
74 |
Targeted nanoagents for the detection of cancers
|
McCarthy, Jason R. |
|
2010 |
|
6 |
p. 511-528 18 p. |
artikel |
75 |
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle
|
Gillis, Ad J.M. |
|
2013 |
|
6 |
p. 1083-1092 10 p. |
artikel |
76 |
Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients
|
Simpson, K. |
|
2015 |
|
6 |
p. 1186-1193 8 p. |
artikel |
77 |
The design and optimization of RNA trans-splicing molecules for skin cancer therapy
|
Gruber, Christina |
|
2013 |
|
6 |
p. 1056-1068 13 p. |
artikel |
78 |
The dream and reality of histology agnostic cancer clinical trials
|
Lacombe, Denis |
|
2014 |
|
6 |
p. 1057-1063 7 p. |
artikel |
79 |
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
|
Li, Zhongwu |
|
2015 |
|
6 |
p. 1091-1105 15 p. |
artikel |
80 |
The role of histone demethylases in cancer therapy
|
Hoffmann, Inga |
|
2012 |
|
6 |
p. 683-703 21 p. |
artikel |
81 |
Tissue proteomics of the human mammary gland: Towards an abridged definition of the molecular phenotypes underlying epithelial normalcy
|
Moreira, José M.A. |
|
2010 |
|
6 |
p. 539-561 23 p. |
artikel |
82 |
Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers
|
Sønderstrup, Ida Marie Heeholm |
|
2015 |
|
6 |
p. 1207-1217 11 p. |
artikel |
83 |
Trials with ‘epigenetic’ drugs: An update
|
Nebbioso, Angela |
|
2012 |
|
6 |
p. 657-682 26 p. |
artikel |
84 |
Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells
|
Liu, Jia |
|
2013 |
|
6 |
p. 1043-1055 13 p. |
artikel |
85 |
Tumour heterogeneity and the evolution of polyclonal drug resistance
|
Burrell, Rebecca A. |
|
2014 |
|
6 |
p. 1095-1111 17 p. |
artikel |
86 |
Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. elegans
|
Mitchell, Christopher J. |
|
2016 |
|
6 |
p. 910-920 11 p. |
artikel |